Jpmorgan Chase & CO Syros Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.69 - $1.21 $21,824 - $38,271
-31,629 Reduced 91.58%
2,908 $3,000
Q1 2022

May 11, 2022
BUY
$1.02 - $3.8 $6,904 - $25,722
6,769 Added 24.38%
34,537 $41,000
Q4 2021

Feb 10, 2022
BUY
$3.26 - $4.66 $3,618 - $5,172
1,110 Added 4.16%
27,768 $91,000
Q3 2021

Nov 12, 2021
BUY
$4.08 - $5.66 $108,764 - $150,884
26,658 New
26,658 $120,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.86M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email